Source link : https://www.newshealth.biz/health-news/novo-nordisks-new-cagrisema-obesity-drug-trial-to-begin-on-feb-10-clinicaltrials-gov-entry-shows/
LONDON (Reuters) – Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a www.clinicaltrials.gov entry. The Danish drugmaker last month revealed disappointing results in a late-stage trial of CagriSema, wiping as much as $125 billion off its market value. It said then that it […]
Author : News Health
Publish date : 2025-01-30 14:42:34
Copyright for syndicated content belongs to the linked Source.